Search Results 481-490 of 13449 for BPC-157

  1. BONAPH1DE - Mayo Clinic

    study will also be utilized to further characterize the natural history and real-world clinical management of patients diagnosed with PH1, as well as the long- ...

  2. A Study Of BBI608 Combined With Standard Chemotherapies In Adult Patients Who Have Pancreatic Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A Study To Evaluate The Safety, Tolerability And Microbiome Dynamics Of SER-287 In Subjects With Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

  4. Metastatic (Stage 4) Breast Cancer Clinical Trials - Mayo Clinic Research

    RATIONALE: Drugs used in chemotherapy, such as brostallicin and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells ...

  5. A Study Of AO-176 As Monotherapy Combinated With Bortezomib And Dexamethasone In Adults With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety and tolerability of AO-176, including dose-limiting toxicities (DLT), ...

  6. Drugs and Supplements that Start with B - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “B” to learn about drug side effects, proper use and ...

  7. A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

  8. To Assess The Efficacy, Safety, And Tolerability Of INCB000928 In Participants With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer - Mayo Clinic

    A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer.

  10. Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride (oral route) - Mayo Clinic

    Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride combination is used to cleanse the bowels ...